{"product_id":"natura-inside-full-spectrum-cannabis-oil-30-cbd-with-piperine-ydor-series-10ml","title":"Natura Inside Full Spectrum Cannabis Oil – 30% CBD with Piperine, Ydor Series, 10ml","description":"\u003ch3\u003e\u003cstrong\u003eCBD Oil 30% (10ml)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThis high-concentration oil contains \u003cstrong\u003e30% CBD (3000 mg per 10 ml)\u003c\/strong\u003e, derived from \u003cem\u003eCannabis sativa L.\u003c\/em\u003e, and is formulated with a \u003cstrong\u003efull spectrum of natural cannabinoids\u003c\/strong\u003e, terpenes, and other plant compounds. It offers a \u003cstrong\u003eclean botanical profile\u003c\/strong\u003e, enriched with \u003cstrong\u003epiperine\u003c\/strong\u003e for enhanced composition.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e🌿 \u003cstrong\u003eKey Features\u003c\/strong\u003e\u003cbr\u003e• 30% CBD – 3000 mg per 10 ml\u003cbr\u003e• Full-spectrum extract from \u003cem\u003eCannabis sativa L.\u003c\/em\u003e\u003cbr\u003e• Contains piperine (black pepper extract)\u003cbr\u003e• Natural carrier oils: MCT (C8\/C10 triglycerides) derived from coconut oil, Greek olive oil, and cold-pressed sunflower oil\u003cbr\u003e• Neutral, earthy taste from plant terpenes\u003cbr\u003e• No artificial ingredients, preservatives, or solvents\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e🧪 \u003cstrong data-start=\"99\" data-end=\"113\"\u003eHow to Use\u003c\/strong\u003e\u003cbr data-start=\"113\" data-end=\"116\"\u003e• Shake well before use\u003cbr data-start=\"139\" data-end=\"142\"\u003e• Apply a small amount 2–3 times daily, preferably every day\u003cbr data-start=\"280\" data-end=\"283\"\u003e• Store in a cool, dark place at room temperature (15–25 °C)\u003c\/p\u003e\n\u003cp data-end=\"243\" data-start=\"98\"\u003e\u003cem data-end=\"241\" data-start=\"121\"\u003eWant to learn more about cannabidiol and its properties in oral care and wellness products? Check out this short blog.\u003c\/em\u003e\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003e🧬 \u003cstrong\u003eCannabidiol (CBD) and Scientifically Documented Properties\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cp\u003eCannabidiol (CBD) is a natural phytocannabinoid derived from the \u003cem\u003eCannabis sativa\u003c\/em\u003e plant. Unlike tetrahydrocannabinol (THC), CBD is \u003cstrong\u003enon-psychoactive\u003c\/strong\u003e, making it safe for daily use¹. It interacts with the \u003cstrong\u003eendocannabinoid system (ECS)\u003c\/strong\u003e, which regulates key physiological functions such as anxiety, pain, sleep, and immune balance².\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e📌 \u003cstrong\u003eKey Properties Identified in Scientific Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003cstrong\u003eAnxiety and stress relief\u003c\/strong\u003e: CBD appears to interact with serotonin receptors, contributing to anxiolytic effects³. It has been studied in cases of social anxiety, generalized anxiety disorder, and PTSD.\u003cbr\u003e• \u003cstrong\u003eSleep support\u003c\/strong\u003e: Research shows that CBD may improve sleep quality and duration, particularly when sleep disturbances are related to anxiety⁴.\u003cbr\u003e• \u003cstrong\u003eAnti-inflammatory and analgesic properties\u003c\/strong\u003e: CBD influences CB1, CB2, and TRPV1 receptors, supporting relief from chronic or neuropathic pain and reducing inflammation⁵.\u003cbr\u003e• \u003cstrong\u003ePhysiological balance (homeostasis)\u003c\/strong\u003e: By modulating the ECS, CBD may help support general wellbeing and internal balance⁶.\u003cbr\u003e• \u003cstrong\u003eAntioxidant and immunomodulatory effects\u003c\/strong\u003e: Experimental data suggest CBD may reduce pro-inflammatory cytokines and support immune response⁷.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003e🦷 \u003cstrong\u003eCBD in Oral Care Applications\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cp\u003eRecent \u003cstrong\u003ein vitro\u003c\/strong\u003e studies have evaluated CBD for topical use in the oral cavity due to its \u003cstrong\u003eantimicrobial, anti-inflammatory, and soothing properties⁸\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e• Shows antimicrobial activity against common oral pathogens such as \u003cem\u003eStreptococcus mutans\u003c\/em\u003e and \u003cem\u003ePorphyromonas gingivalis⁸\u003c\/em\u003e\u003cbr\u003e• Demonstrates effects comparable or superior to chlorhexidine, without side effects like staining⁹\u003cbr\u003e• Well tolerated by oral tissues — no irritation, burning, or discoloration⁸\u003cbr\u003e• Effectively stabilized in carrier oils such as MCT and olive oil, which enhance delivery in oral formulations⁸\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cstrong\u003eNote:\u003c\/strong\u003e This product is registered in the European CPNP database with \u003cstrong\u003eNotification Number: CPNP 4470920\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThe information presented is based on published scientific literature regarding \u003cstrong\u003ecannabidiol (CBD)\u003c\/strong\u003e as a compound and \u003cstrong\u003edoes not constitute a health claim\u003c\/strong\u003e for the final product. This product is \u003cstrong\u003enot intended to diagnose, treat, cure, or prevent any disease\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e📚 \u003cstrong\u003eReferences\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003eWorld Health Organization. (2018). \u003cem\u003eCannabidiol (CBD) Critical Review Report\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eLowe, H. I. C., Toyang, N. J., \u0026amp; McLaughlin, W. (2021). \u003cem\u003eMedicines\u003c\/em\u003e, 8(6), 44. \u003ca href=\"https:\/\/doi.org\/10.3390\/molecules26237216\"\u003ehttps:\/\/doi.org\/10.3390\/medicines8060044\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eBlessing, E. M., et al. (2015). \u003cem\u003eNeurotherapeutics\u003c\/em\u003e, 12(4), 825–836. \u003ca href=\"https:\/\/doi.org\/10.1007\/s13311-015-0387-1\"\u003ehttps:\/\/doi.org\/10.1007\/s13311-015-0387-1\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eShannon, S., et al. (2019). \u003cem\u003eThe Permanente Journal\u003c\/em\u003e, 23. \u003ca href=\"https:\/\/doi.org\/10.7812\/TPP\/18-041\"\u003ehttps:\/\/doi.org\/10.7812\/TPP\/18-041\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eWhiting, P. F., et al. (2015). \u003cem\u003eJAMA\u003c\/em\u003e, 313(24), 2456–2473. \u003ca href=\"https:\/\/doi.org\/10.1001\/jama.2015.6358\"\u003ehttps:\/\/doi.org\/10.1001\/jama.2015.6358\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eNichols, J. M., \u0026amp; Kaplan, B. L. (2020). \u003cem\u003eCannabis and Cannabinoid Research\u003c\/em\u003e, 5(1), 12–31. \u003ca href=\"https:\/\/doi.org\/10.1089\/can.2018.0073\"\u003ehttps:\/\/doi.org\/10.1089\/can.2018.0073\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eKozela, E., et al. (2011). \u003cem\u003eJournal of Neuroimmune Pharmacology\u003c\/em\u003e, 6(3), 529–540. \u003ca href=\"https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01379.x\" aria-label=\"Digital Object Identifier for Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL\/6 mice link\" class=\"epub-doi\"\u003ehttps:\/\/doi.org\/10.1111\/j.1476-5381.2011.01379.x\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eStahl, V., \u0026amp; Vasudevan, K. (2020). \u003cem\u003eCureus\u003c\/em\u003e, 12(1), e6809. \u003ca href=\"https:\/\/doi.org\/10.7759\/cureus.6809\"\u003ehttps:\/\/doi.org\/10.7759\/cureus.6809\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eIffland, K., \u0026amp; Grotenhermen, F. (2017). \u003cem\u003eCannabis and Cannabinoid Research\u003c\/em\u003e, 2(1), 139–154. \u003ca href=\"https:\/\/doi.org\/10.1089\/can.2016.0034\"\u003ehttps:\/\/doi.org\/10.1089\/can.2016.0034\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eRegulation (EU) No 1307\/2013 and Directive 2002\/46\/EC – \u003cstrong\u003eEU compliance on hemp and novel foods\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"Natura Inside","offers":[{"title":"Default Title","offer_id":53231330984264,"sku":"LA2930","price":28.53,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0968\/7603\/6424\/files\/30.webp?v=1780577080","url":"https:\/\/sojsupplements.com\/products\/natura-inside-full-spectrum-cannabis-oil-30-cbd-with-piperine-ydor-series-10ml","provider":"SOJ Supplements","version":"1.0","type":"link"}